ID: ALA2311986

Max Phase: Preclinical

Molecular Formula: C19H22N2O4

Molecular Weight: 342.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(CN)Oc1ccc2oc3ccc(OC(C)CN)cc3c(=O)c2c1

Standard InChI:  InChI=1S/C19H22N2O4/c1-11(9-20)23-13-3-5-17-15(7-13)19(22)16-8-14(24-12(2)10-21)4-6-18(16)25-17/h3-8,11-12H,9-10,20-21H2,1-2H3

Standard InChI Key:  QLFRNINFCGCFCZ-UHFFFAOYSA-N

Associated Targets(Human)

Endoribonuclease Dicer 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 342.40Molecular Weight (Monoisotopic): 342.1580AlogP: 2.40#Rotatable Bonds: 6
Polar Surface Area: 100.71Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.43CX LogP: 1.88CX LogD: -1.54
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.67Np Likeness Score: 0.00

References

1. Murata A, Fukuzumi T, Umemoto S, Nakatani K..  (2013)  Xanthone derivatives as potential inhibitors of miRNA processing by human Dicer: targeting secondary structures of pre-miRNA by small molecules.,  23  (1): [PMID:23164709] [10.1016/j.bmcl.2012.10.108]

Source